(Q33946539)

30 July 2017

1 reference

title

Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: II. Glutamate (Ant)agonists (English)

1 reference

30 July 2017

0 references

1 reference

M L Carfagno

1

1 reference

30 July 2017

L A Hoskins

2

1 reference

30 July 2017

M E Pinto

3

1 reference

30 July 2017

J C Yeh

4

1 reference

30 July 2017

R B Raffa

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Annals of Pharmacotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

34

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

788-797

1 reference

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

30 July 2017

cites work

1 reference

Glutamate: a new target in schizophrenia?

21 January 2018

1 reference

The Mechanism of Action of Novel Antipsychotic Drugs

21 January 2018

1 reference

Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists

21 January 2018

1 reference

Schizophrenia as a recent disease

21 January 2018

1 reference

Cultural and temporal variations in schizophrenia: a speculation on the importance of industrialization

21 January 2018

1 reference

Was insanity on the increase? The fifty-sixth Maudsley Lecture

21 January 2018

1 reference

Viral antigen distribution in the central nervous system of cattle persistently infected with bovine viral diarrhea virus

21 January 2018

1 reference

Antipsychotic drug effects on glutamatergic activity

21 January 2018

1 reference

Developments in the drug treatment of schizophrenia

21 January 2018

1 reference

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

The metabotropic glutamate receptors: structure and functions

21 January 2018

1 reference

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

21 January 2018

1 reference

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 January 2018

1 reference

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

21 January 2018

1 reference

The neuroanatomy and neurochemistry of schizophrenia

21 January 2018

1 reference

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

21 January 2018

1 reference

Biological research on schizophrenia

21 January 2018

1 reference

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

21 January 2018

1 reference

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis

21 January 2018

1 reference

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia

21 January 2018

1 reference

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

21 January 2018

1 reference

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

21 January 2018

1 reference

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls

21 January 2018

1 reference

Amino acid patterns in schizophrenia: Some new findings

21 January 2018

1 reference

Cerebrospinal fluid amino acid concentrations in chronic schizophrenia

21 January 2018

1 reference

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

21 January 2018

1 reference

Cell biology of the hippocampal formation in schizophrenia

21 January 2018

1 reference

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

21 January 2018

1 reference

Phencyclidine-induced psychosis

21 January 2018

1 reference

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications

21 January 2018

1 reference

Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation

21 January 2018

1 reference

Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain

21 January 2018

1 reference

Metabotropic Glutamate Receptor Activation Produces Extrapyramidal Motor System Activation That Is Mediated by Striatal Dopamine

21 January 2018

1 reference

Metabotropic glutamate receptors depress glutamate-mediated synaptic input to rat midbrain dopamine neurones in vitro

21 January 2018

1 reference

Aging reduces neostriatal responsiveness to N-methyl-D-aspartate and dopamine: an in vitro electrophysiological study

21 January 2018

1 reference

Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801.

21 January 2018

1 reference

Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.

21 January 2018

1 reference

Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions

21 January 2018

1 reference

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

21 January 2018

1 reference

Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex

21 January 2018

1 reference

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

21 January 2018

1 reference

Glutamate in schizophrenia: clinical and research implications

21 January 2018

1 reference

Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

21 January 2018

1 reference

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats

21 January 2018

1 reference

Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats.

21 January 2018

1 reference

Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia

21 January 2018

1 reference

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

21 January 2018

1 reference

The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans

21 January 2018

1 reference

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

Presynaptic dopaminergic modulation of cortical input to the striatum

21 January 2018

1 reference

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

21 January 2018

1 reference

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

THE GENETIC THEORY OF SCHIZOPHRENIA

21 January 2018

1 reference

Psychiatric Disorders in Foster Home Reared Children of Schizophrenic Mothers

21 January 2018

1 reference

Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

21 January 2018

1 reference

Twin concordance for DSM-III-R schizophrenia

21 January 2018

1 reference

The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives

21 January 2018

1 reference

Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark

21 January 2018

1 reference

A turning point in schizophrenia genetics

21 January 2018

1 reference

Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.

21 January 2018

1 reference

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

21 January 2018

1 reference

A new route to treating schizophrenia?

21 January 2018

1 reference

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

21 January 2018

1 reference

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

21 January 2018

1 reference

Excitatory amino acids: implications for psychiatric disorders research

21 January 2018

1 reference

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

21 January 2018

1 reference

A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction

21 January 2018

1 reference

Pharmacology and functions of metabotropic glutamate receptors

21 January 2018

1 reference

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19146

1 reference

30 July 2017

1 reference